Application of highly sensitive next-generation sequencing (NGS)-based methodology has recently shown that GATA1 mutations are present in all cases of TAM or ML-DS and that they are present in 25–30 % of all neonates with Down syndrome [11••]. The gene discussed is GATA1; the disease is Down syndrome.